These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 20628034)

  • 1. A proposal of measures for monitoring social disparities in health using AIDS and liver disease mortality before and after HAART.
    Regidor E; Sánchez E; de la Fuente L; Santos JM; Martínez D
    Eur J Public Health; 2011 Feb; 21(1):116-21. PubMed ID: 20628034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major reduction in AIDS-mortality inequalities after HAART: the importance of absolute differences in evaluating interventions.
    Regidor E; Sánchez E; de la Fuente L; Luquero FJ; de Mateo S; Domínguez V
    Soc Sci Med; 2009 Feb; 68(3):419-26. PubMed ID: 19056156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of education on overall and cause-specific mortality in injecting drug users, according to HIV and introduction of HAART.
    Jarrin I; Lumbreras B; Ferreros I; Pérez-Hoyos S; Hurtado I; Hernández-Aguado I
    Int J Epidemiol; 2007 Feb; 36(1):187-94. PubMed ID: 17085455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIDS mortality before and after the introduction of highly active antiretroviral therapy: does it vary with socioeconomic group in a country with a National Health System?
    Borrell C; Rodríguez-Sanz M; Pasarín MI; Brugal MT; García-de-Olalla P; Marí-Dell'Olmo M; Caylà J
    Eur J Public Health; 2006 Dec; 16(6):601-8. PubMed ID: 16698886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998.
    Louie JK; Hsu LC; Osmond DH; Katz MH; Schwarcz SK
    J Infect Dis; 2002 Oct; 186(7):1023-7. PubMed ID: 12232845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
    Wong KH; Chan KC; Lee SS
    Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
    Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
    Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy).
    Farmer P; Léandre F; Mukherjee J; Gupta R; Tarter L; Kim JY
    Bull World Health Organ; 2001; 79(12):1145-51. PubMed ID: 11799447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Change in the survival of Cuban AIDS patients with tuberculosis in the Highly Active Antiretroviral Therapy (HAART) era].
    Reyes-Corcho A; Capo de Paz V; Díaz-Jidy M; Pérez-Avila J; Bouza-Jiménez Y
    Invest Clin; 2008 Sep; 49(3):309-20. PubMed ID: 18846772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel use of AIDS surveillance data to assess the impact of initial treatment regimen on survival.
    Chen SY; Moss WJ; Pipkin SS; McFarland W
    Int J STD AIDS; 2009 May; 20(5):330-5. PubMed ID: 19386970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HAART slashed AIDS death rates by 80 percent.
    IAPAC Mon; 2003 Nov; 9(11):279. PubMed ID: 14989186
    [No Abstract]   [Full Text] [Related]  

  • 12. The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS.
    Hessol NA; Pipkin S; Schwarcz S; Cress RD; Bacchetti P; Scheer S
    Am J Epidemiol; 2007 May; 165(10):1143-53. PubMed ID: 17344204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy.
    Antinori A; Larussa D; Cingolani A; Lorenzini P; Bossolasco S; Finazzi MG; Bongiovanni M; Guaraldi G; Grisetti S; Vigo B; Gigli B; Mariano A; Dalle Nogare ER; De Marco M; Moretti F; Corsi P; Abrescia N; Rellecati P; Castagna A; Mussini C; Ammassari A; Cinque P; d'Arminio Monforte A;
    Clin Infect Dis; 2004 Dec; 39(11):1681-91. PubMed ID: 15578371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Universal decline in mortality in patients with advanced HIV-1 disease in various demographic subpopulations after the introduction of HAART in Hong Kong, from 1993 to 2002.
    Chan KC; Wong KH; Lee SS
    HIV Med; 2006 Apr; 7(3):186-92. PubMed ID: 16494633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Economic and socio-behavioural issues related to highly active antiretroviral therapies for HIV infection: the contribution of social science research].
    Moatti JP; Spire B
    Med Sci (Paris); 2003; 19(8-9):878-84. PubMed ID: 14593621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical impacts of highly active antiretroviral therapy on patients of hemophilia combined with acquired immunodeficiency syndrome: 6-year follow-up of 39 cases].
    Dai ZS; Zhang XX; Wang JR; Zhang YJ; Sun HQ; Lu HZ
    Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(13):872-5. PubMed ID: 19671284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area.
    Martínez E; Milinkovic A; Buira E; de Lazzari E; León A; Larrousse M; Loncá M; Laguno M; Blanco JL; Mallolas J; García F; Miró JM; Gatell JM
    HIV Med; 2007 May; 8(4):251-8. PubMed ID: 17461853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [EuroSIDA Study: downward trend of AIDS cases and AIDS mortality].
    Blasko M
    Dtsch Med Wochenschr; 2003 Sep; 128(36):1814. PubMed ID: 14518432
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study on the effect of treatment and the status of drug resistance among HIV/AIDS patients treated with highly active antiretroviral therapy in Shandong province].
    Zhang J; Lin B; Lin L; Yang PJ; Fu JH; Li HP; Li JY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Nov; 28(11):1108-11. PubMed ID: 18396667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of HIV infection in the post-HAART era among a cohort of HIV+ Greek haemophilia patients.
    Katsarou O; Touloumi G; Antoniou A; Kouramba A; Hatzakis A; Karafoulidou A
    Haemophilia; 2005 Jul; 11(4):360-5. PubMed ID: 16011588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.